Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement. | Front Immunol | 2022 | 35911683 | PubTator, text mining | PubMed |
| Multi-Data Integration Towards a Global Understanding of the Neurological Impact of Human Brain Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | Front Integr Neurosci | 2022 | 35910337 | PubTator, text mining | PubMed |
| Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs. | Oncoimmunology | 2022 | 35909944 | PubTator, text mining | PubMed |
| [Consideration on the Research and Development of New Drugs for Rare Tumors]. | Zhongguo Fei Ai Za Zhi | 2022 | 35899439 | PubTator, text mining | PubMed |
| FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis. | Antibodies (Basel) | 2022 | 35892705 | PubTator, text mining | PubMed |
| Childhood B-Cell Preleukemia Mouse Modeling. | Int J Mol Sci | 2022 | 35886910 | PubTator, text mining | PubMed |
| PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas. | Biomedicines | 2022 | 35884893 | PubTator, text mining | PubMed |
| Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. | J Clin Invest | 2022 | 35881486 | PubTator, text mining | PubMed |
| The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma. | BMC Cancer | 2022 | 35879680 | PubTator, text mining | PubMed |
| Recent Discoveries on Marine Organism Immunomodulatory Activities. | Mar Drugs | 2022 | 35877715 | PubTator, text mining | PubMed |
| Short Stature and Celiac Disease in Children (5 to 16 Years) Presenting at a Tertiary Care Hospital in Peshawar. | Cureus | 2022 | 35875306 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung Cancer. | Front Immunol | 2022 | 35874785 | PubTator, text mining | PubMed |
| CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure. | Front Immunol | 2022 | 35874685 | PubTator, text mining | PubMed |
| Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells. | Sci Immunol | 2022 | 35867801 | PubTator, text mining | PubMed |
| Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma. | Front Oncol | 2022 | 35865478 | PubTator, text mining | PubMed |
| Identification of Novel Tumor Microenvironment Regulating Factor That Facilitates Tumor Immune Infiltration in Cervical Cancer. | Front Oncol | 2022 | 35847936 | PubTator, text mining | PubMed |
| B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma. | Front Oncol | 2022 | 35847892 | PubTator, text mining | PubMed |
| Richter transformation with marked plasmacytic differentiation, mimicking plasma cell neoplasm. | EJHaem | 2022 | 35846217 | PubTator, text mining | PubMed |
| Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic review. | EJHaem | 2022 | 35846186 | PubTator, text mining | PubMed |
| A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia. | Ann Transl Med | 2022 | 35845522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=60